Pedialyte or Gatorade for Viral Gastroenteritis in Adults: a Randomized, Controlled Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00257374|
Recruitment Status : Completed
First Posted : November 22, 2005
Last Update Posted : January 9, 2014
Background: Pedialyte and Gatorade are advocated for the treatment of dehydration in viral gastroenteritis, but there is limited evidence to support their use.
Objective: To examine the efficacy, safety and palatability of Pedialyte, Gatorade, and a New Oral Rehydration Solution (NS).
Design: Randomized double blind. Setting: Inpatient, community hospital. Patients/Interventions: 75 consecutive adult patients (m/f=44/33) admitted with viral gastroenteritis were randomized to receive Gatorade, Pedialyte or NS for 48 hours. A yogurt/rice diet was allowed ad libitum.
Measurements: Stool and urine output, electrolytes, fluid intake, body weight, hematocrit and palatability of solutions.
Limitations: Smaller sample size and higher drop out (20%).
|Condition or disease||Intervention/treatment||Phase|
|Gastroenteritis||Drug: Gatorade, Pedialyte and New Solution||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Parallel Assignment|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00257374
|Dept. of Gastroenterology & Infectious Disease, Osmania Medical College|
|Hyderabad, India, 500012|
|Principal Investigator:||Satish SC Rao, MD,PhD, FRCP(LON)||University of Iowa|